Oesophageal Doppler Monitoring has gained support from a number of clinical and regulatory bodies, both within the UK and internationally. Robust evidence demonstrates reduced post-operative complications and hospital length of stay.

March 2011 saw the publication of the NICE Medical Technology Guidance for CardioQ-ODM Oesophageal Doppler Monitor (MTG3). The recommendation is specifically for the use of the CardioQ-ODM Oesophageal Doppler Monitor to guide fluid optimisation during surgery in over 800,000 procedures in England annually. The CardioQ-ODM is the only technology with sufficient evidence-base to support such extensive recommendation and guidance. Read More

The British Consensus Guidelines on Intravenous Therapy for Adult Surgery (GIFTASUP) were released in 2008, for dissemination to members of participating professional bodies. GIFTASUP states that a response in SV should be assessed using flow-based technology, intraoperative treatment can reduce complication rates and length of hospital stay and that postoperative monitoring should be carried out in non-elective abdominal and orthopaedic surgery. Read More

The NHS Technology Adoption Centre (NTAC) conducted an audit in over 1300 patients, undergoing a range of surgical procedures in three NHS hospitals. Following the comprehensive evidence from the RCTs, NTAC wanted to determine whether clinicians could be trained to use ODM in ‘real world’ hospital settings and gain the same benefits observed in the tightly controlled clinical studies. Read More

The Société Francais d’Anesthésie et de Réanimation (SFAR) have recently released a set of guidelines entitled ‘Stratégie du remplissage vasculaire périopératoire’ (Guidelines for perioperative haemodynamic optimisation), which are SFAR Board approved. The objective is to ‘highlight perioperative vascular filling practices (VF) as a benefit for patients, for use in daily practice’. The first three recommendations relate directly to ODM and Fluid Management and received the highest possible rating of GRADE1+. Read More